Full-Time

Clinical Regulatory Affairs Specialist 2

Posted on 1/24/2026

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

Compensation Overview

$69.9k - $78.7k/yr

+ Bonus

Rockford, IL, USA

In Person

Category
Legal & Compliance (2)
,
Required Skills
Google Cloud Platform
Requirements
  • Bachelor's Degree in a related field and/or 5-10 years related experience and/or training
  • Basic Mathematical Skills
  • Intermediate Computer Skills: Ability to perform more complex computer tasks and has knowledge of various computer programs
  • Full Professional Proficiency: Ability to speak, read, and write fluently and accurately on all levels pertinent to professional needs
  • High Reasoning: Ability to solve practical problems and deal with a variety of concrete variables in situations where there is only limited standardization. Ability to interpret a variety of instructions that may be provided in various forms
  • High Standard of Report Writing
  • Knowledge of and adherence to all PCI, cGMP, and GCP policies, procedures, rules
Responsibilities
  • Write and implement procedures according to the current Code of Federal Regulations
  • Assure that company policies are properly followed and applied by all appropriate personnel
  • Assists the Regulatory Affairs Manager by hosting audits, developing appropriate corrective actions documented through the audit reports and ensuring proper implementation
  • Oversee regular inventories of Controlled Substances for ARCOS reporting and required inventory reports
  • Acts as a subject matter expert to other internal resources for concepts within 21CFR 210 & 211 as well as the Control Substances Act
  • Create, review and maintain appropriate Clinical Customer Quality Agreements both globally and site specific
  • Review and maintain appropriate Site Master Files
  • Manage and monitor Audit Corrective Actions
  • Write audit responses pertaining to customer and/or internal observations, and track completion of actions
  • Review investigations associated with DEA Controlled Products
  • Submit applicable registration applications
  • Prepare and present monthly Clinical metrics including Customer specific and overall departmental values
  • This position may require overtime and/or weekend work
  • Knowledge of and adherence to all PCI, cGMP, and GCP policies, procedures, rules
  • Attendance to work is an essential function of this position
  • Performs other duties as assigned by Manager/Supervisor
Desired Qualifications
  • Ability to work independently and/or as part of a team
  • Ability to demonstrate attention to detail
  • Ability to identify and resolve problems in a timely manner
  • Ability to hold oneself in a professional manner

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • San Diego’s 2028 line more than doubles RTU syringe and cartridge capacity.
  • Bedford’s line reaches 33 million annual vial units, strengthening sterile supply.
  • Autoinjector capacity exceeds 250 million units annually after the 2027 line.

What critics are saying

  • San Diego capacity arrives only in first-half 2028, leaving competitors more immediate supply.
  • Large sterile buildouts create execution risk from validation, yield, and regulatory delays.
  • Customer concentration can strand expensive capacity if programs are delayed or cancelled.

What makes PCI Pharma Services unique

  • PCI combines sterile fill-finish, device assembly, packaging, and cold-chain support.
  • San Diego and Bedford add specialized capacity for prefilled syringes, vials, and lyophilization.
  • Phased U.S. and European investments target clinical-through-commercial drug-device programs.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at PCI Pharma Services who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE